Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The Company's technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The Company focuses on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage. Its product, in addition to detecting the structural changes attributed to cervical cancer, is also detects the biochemical changes that precede the development of visual lesions. LuViva consists of three components: Touch screen monitor, Hand Held Unit (HHU) and the Wheeled Base.
|Headquarters||5835 Peachtree Cors E Ste D|
NORCROSS, GA, United States 30092-3413
|Independent Chairman and Director||Michael James|
|Chief Executive Officer, Acting Chief Financial Officer, President and Director||Gene Cartwright|
|Senior Vice President - Engineering||Richard Fowler|
|Independent Director||John Imhoff|
|Independent Director||Jonathan Niloff|
|Shares Out.||153.9M||Book Value||$-2.35|
|Guided Therapeutics Inc does not pay a dividend.||P/E||--|
|P/Cash Flow (TTM)||--|
*GAAP = prior to non-GAAP analyst adjusted earnings.